<style face="normal" font="default" size="100%">Efficacy and Safety of Tocilizumab in Monotherapy, an Anti-II-6 Receptor Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis: Results from a 24 Week Double-Blind Phase III Study</style>

Drupal-HighWire